Search by Drug Name, NDC or Jcode

    Internal Navigation

    HCPCS Details

    HCPC J2562
    Short Description Plerixafor injection
    Long Description Injection, plerixafor, 1 mg
    Pricing indicator 51
    Coverage code C
    ASC payment group code YY
    BETOS2 code O1E
    Action code N
    Type of service 1
    Effective date 2010-01-01
    Date Added 2010-01-01

    HCPCS/NDC Cross-Walk

    NDC HCPC Description Drug Name Labeler Name HCPCS Dosage PKG Size PKG QTY Bill Units Bill Units PKG
    00024586201 J2562 Plerixafor injection Mozobil (PLERIXAFOR) SANOFI-AVENTIS 1 MG 1.2 1 24 24
    00480432001 J2562 Plerixafor injection PLERIXAFOR TEVA PHARMACEUTICALS USA 1 MG 1.2 1 24 24
    55150035601 J2562 Plerixafor injection PLERIXAFOR EUGIA US LLC 1 MG 1.2 1 24 24
    70121169402 J2562 Plerixafor injection PLERIXAFOR AMNEAL BIOSCIENCES 1 MG 1.2 1 24 24
    70710120801 J2562 Plerixafor injection Plerixafor ZYDUS PHARMACEUTICALS (USA) 1 MG 1.2 1 24 24
    71288015501 J2562 Plerixafor injection Plerixafor MEITHEAL PHARMACEUTICALS 1 MG 1.2 1 24 24
    The ASP crosswalks are maintained by the Division of Data Analysis and Market Based Pricing to support ASP-based Medicare Part B payments only. The crosswalks are intended to help the public (including entities that submit manufacturer ASP data and providers who bill for drugs) understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes. The crosswalks are not intended to be a comprehensive list of all drugs/NDCs available in the United States. The NDC to HCPCS Crosswalk also includes information on the NDC package size and the number of billable units (as defined by the HCPCS code descriptor). Comments on the file may be sent to [email protected].

    HCPCS Billing Calculator

    Dosage given to patient (per dose)
    HCPCS Dosage 1 MG
    HCPCS/CPT Billing Units 1
    Total doses ordered
    Billing Units 1

    Drug Details

    • Plerixafor injection is used along with a granulocyte-colony stimulating factor (G-CSF) medication such as filgrastim (Neupogen) or pegfilgrastim (Neulasta) to prepare the blood for an autologous stem cell transplant (procedure in which certain blood cells are removed from the body and then returned to the body after chemotherapy and/or radiation) in patients with non-Hodgkin's lymphoma (NHL; cancer that begins in a type of white blood cells that normally fights infection) or multiple myeloma (a type of cancer of the bone marrow). Plerixafor injection is in a class of medications called hematopoeitic stem cell mobilizers. It works by causing certain blood cells to move from the bone marrow to the blood so that they can be removed for transplant.